Get 40% Off
💰 Buffett reveals a $6.7B stake in Chubb. Copy the full portfolio for FREE with InvestingPro’s Stock Ideas toolCopy Portfolio

Top Ranked Momentum Stocks To Buy For September 27th

Published 09/27/2019, 12:21 AM
Updated 07/09/2023, 06:31 AM
AEP
-

Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, September 27th:

Aclaris Therapeutics, Inc. (ACRS): This biopharmaceutical company has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 2.8% over the last 60 days.

Aclaris Therapeutics, Inc. Price and Consensus

Aclaris Therapeutics' shares gained 23% over the last one month compared to S&P 500’s rise of 4%. The company possesses a Momentum Score of A.

Aclaris Therapeutics, Inc. Price

American Electric Power (AEP): This electric public utility holding company has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 0.2% over the last 60 days.

American Electric Power Company (NYSE:AEP), Inc. Price and Consensus

American Electric Power's shares gained 4.3% over the last one month. The company possesses a Momentum Score of A.

American Electric Power Company, Inc. Price

Ally Financial Inc. (ALLY): This provider of financial products and services has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 0.5% over the last 60 days.

Ally Financial Inc. Price and Consensus

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Air Industries’ shares gained 10.2% over the last one month. The company possesses a Momentum Score of B.

Ally Financial Inc. Price

See the full list of top ranked stocks here

Learn more about the Momentum score and how it is calculated here.

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>



Ally Financial Inc. (ALLY): Free Stock Analysis Report

American Electric Power Company, Inc. (AEP): Free Stock Analysis Report

Aclaris Therapeutics, Inc. (ACRS): Free Stock Analysis Report

Original post

Zacks Investment Research

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.